
<ns0:uwmetadata xmlns:ns0="http://phaidra.univie.ac.at/XML/metadata/V1.0" xmlns:ns1="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0" xmlns:ns10="http://phaidra.univie.ac.at/XML/metadata/provenience/V1.0" xmlns:ns11="http://phaidra.univie.ac.at/XML/metadata/provenience/V1.0/entity" xmlns:ns12="http://phaidra.univie.ac.at/XML/metadata/digitalbook/V1.0" xmlns:ns13="http://phaidra.univie.ac.at/XML/metadata/etheses/V1.0" xmlns:ns2="http://phaidra.univie.ac.at/XML/metadata/extended/V1.0" xmlns:ns3="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/entity" xmlns:ns4="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/requirement" xmlns:ns5="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/educational" xmlns:ns6="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/annotation" xmlns:ns7="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/classification" xmlns:ns8="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/organization" xmlns:ns9="http://phaidra.univie.ac.at/XML/metadata/histkult/V1.0">
  <ns1:general>
    <ns1:identifier>o:2359</ns1:identifier>
    <ns1:title language="en">Should Cushing&apos;s Syndrome be Considered as a Disease with High Cardiovascular Risk in Relevant Guidelines?</ns1:title>
    <ns1:language>en</ns1:language>
    <ns1:description language="en">A considerable amount of data supports a 1.8-7.4-fold increased mortality associated with Cushing&apos;s syndrome (CS). This is attributed to a high occurrence of several cardiovascular disease (CVD) risk factors in CS [e.g. adiposity, arterial hypertension (AHT), dyslipidaemia and type 2 diabetes mellitus (T2DM)]. Therefore, practically all patients with CS have the metabolic syndrome (MetS), which represents a high CVD risk. Characteristically, despite a relatively young average age, numerous patients with CS display a &apos;high&apos; or &apos;very high&apos; CVD risk (i.e. risk of a major CVD event &gt;20% in the following 10 years). Although T2DM is listed as a condition with a high CVD risk, CS is not, despite the fact that a considerable proportion of the CS population will develop T2DM or impaired glucose tolerance. CS is also regarded as a risk factor for aortic dissection in current guidelines. This review considers the evidence supporting listing CS among high CVD risk conditions.</ns1:description>
    <ns1:description language="en">Current Vascular Pharmacology vol. 18 br. 1 str. 12-24</ns1:description>
    <ns1:keyword language="sr">Cushing&apos;s syndrome; arterial hypertension; cardiovascular risk factors; diabetes mellitus; metabolic syndrome.</ns1:keyword>
    <ns2:identifiers>
      <ns2:resource>1552099</ns2:resource>
      <ns2:identifier>	10.2174/1570161116666181005122339</ns2:identifier>
    </ns2:identifiers>
    <ns2:identifiers>
      <ns2:resource>1552101</ns2:resource>
      <ns2:identifier>1570-1611</ns2:identifier>
    </ns2:identifiers>
  </ns1:general>
  <ns1:lifecycle>
    <ns1:upload_date>2024-03-05T22:33:42.217Z</ns1:upload_date>
    <ns1:status>44</ns1:status>
    <ns2:peer_reviewed>yes</ns2:peer_reviewed>
    <ns1:contribute seq="0">
      <ns1:role>46</ns1:role>
      <ns1:entity seq="0">
        <ns3:firstname>Goran</ns3:firstname>
        <ns3:lastname>Koraćević</ns3:lastname>
        <ns3:institution>Medicinski fakultet, Univerzitet u Nišu</ns3:institution>
      </ns1:entity>
      <ns1:date>2019</ns1:date>
    </ns1:contribute>
    <ns1:contribute seq="1">
      <ns1:role>46</ns1:role>
      <ns1:entity seq="0">
        <ns3:firstname>Milan </ns3:firstname>
        <ns3:lastname>Stojković</ns3:lastname>
        <ns3:institution>Medicinski fakultet, Univerzitet u Nišu</ns3:institution>
      </ns1:entity>
    </ns1:contribute>
    <ns1:contribute seq="2">
      <ns1:role>46</ns1:role>
      <ns1:entity seq="0">
        <ns3:firstname>Dragan </ns3:firstname>
        <ns3:lastname>Lović</ns3:lastname>
        <ns3:institution>Medicinski fakultet, Univerzitet u Nišu</ns3:institution>
      </ns1:entity>
    </ns1:contribute>
    <ns1:contribute seq="3">
      <ns1:role>46</ns1:role>
      <ns1:entity seq="0">
        <ns3:firstname>Milan </ns3:firstname>
        <ns3:lastname>Pavlović</ns3:lastname>
        <ns3:institution>Medicinski fakultet, Univerzitet u Nišu</ns3:institution>
      </ns1:entity>
    </ns1:contribute>
    <ns1:contribute seq="4">
      <ns1:role>46</ns1:role>
      <ns1:entity seq="0">
        <ns3:firstname>Tomislav</ns3:firstname>
        <ns3:lastname>Kostić</ns3:lastname>
        <ns3:institution>Medicinski fakultet, Univerzitet u Nišu</ns3:institution>
      </ns1:entity>
    </ns1:contribute>
    <ns1:contribute seq="5">
      <ns1:role>46</ns1:role>
      <ns1:entity seq="0">
        <ns3:firstname>Marija</ns3:firstname>
        <ns3:lastname>Kutlešić</ns3:lastname>
        <ns3:institution>Medicinski fakultet, Univerzitet u Nišu</ns3:institution>
      </ns1:entity>
    </ns1:contribute>
    <ns1:contribute seq="6">
      <ns1:role>46</ns1:role>
      <ns1:entity seq="0">
        <ns3:firstname>Slađana</ns3:firstname>
        <ns3:lastname>Micić</ns3:lastname>
        <ns3:institution>Medicinski fakultet, Univerzitet u Nišu</ns3:institution>
      </ns1:entity>
    </ns1:contribute>
    <ns1:contribute seq="7">
      <ns1:role>46</ns1:role>
      <ns1:entity seq="0">
        <ns3:firstname>Maja</ns3:firstname>
        <ns3:lastname>Koraćević</ns3:lastname>
        <ns3:institution>University of Niš, Faculty of Medicine, Niš, Serbia + University of Niš, Innovation Center, Niš, Serbia</ns3:institution>
      </ns1:entity>
    </ns1:contribute>
    <ns1:contribute seq="8">
      <ns1:role>46</ns1:role>
      <ns1:entity seq="0">
        <ns3:firstname>Milan </ns3:firstname>
        <ns3:lastname>Đorđević</ns3:lastname>
        <ns3:institution>Health Centre Jagodina, Serbia</ns3:institution>
      </ns1:entity>
    </ns1:contribute>
  </ns1:lifecycle>
  <ns1:technical>
    <ns1:format>application/pdf</ns1:format>
    <ns1:size>14395214</ns1:size>
    <ns1:location>https://phaidrani.ni.ac.rs/o:2359</ns1:location>
  </ns1:technical>
  <ns1:rights>
    <ns1:cost>no</ns1:cost>
    <ns1:copyright>yes</ns1:copyright>
    <ns1:license>21</ns1:license>
  </ns1:rights>
  <ns1:classification>
    <ns1:purpose>70</ns1:purpose>
  </ns1:classification>
  <ns1:organization>
    <ns8:hoschtyp>92000001</ns8:hoschtyp>
    <ns8:orgassignment>
      <ns8:faculty>18A15</ns8:faculty>
    </ns8:orgassignment>
  </ns1:organization>
</ns0:uwmetadata>
